UnitedHealth Q3 Revenue Reaches $112.7 Billion as Diluted EPS Hits $4.56
UnitedHealth Group (UNH) reported Q3 2026 revenue of $112.7B, down from $113.2B YoY, with diluted EPS at $4.56. Operating earnings rose to $6.6B. The company raised its full-year adjusted net earnings outlook to at least $20.50 per share. UnitedHealthcare and Optum generated $86.3B and $66.9B in revenue, respectively. UNH repurchased $5.0B in stock and paid $6.2B in dividends YTD.
How this was made
The 30-second read
Why it matters
The earnings beat and guidance raise are likely to boost UNH's share price and may influence sector sentiment.
Market read
First‑report earnings with strong guidance lift; high trading relevance for equity investors.
What to watch
Potential headwinds from regulatory scrutiny or rising medical‑care costs could temper upside.
Background
UnitedHealth Group is the largest U.S. health insurer, and its quarterly earnings are closely watched for health‑care sector health.
Ticker impact
UnitedHealth Group reported Q3 2026 revenue of $112.7 B and raised its full‑year adjusted earnings outlook to at least $20.50 per share.
likely upward pressure as investors price in higher earnings guidance
Large‑cap health insurer with material earnings beat and guidance raise; market typically reacts positively.
Market effects
Higher health‑care earnings outlook may lift sector peers and related biotech/insurance stocks.
U.S. market may see modest gains in the health‑care index.
Limited to U.S. equities; no direct global macro effect.
Counterpoint
If the guidance raise is already priced in, the stock could face short‑term profit‑taking.
Key entities
- companyUnitedHealth Group
U.S. health‑care conglomerate reporting Q3 results.
